New Key Statistics Module, Z-Score and F-Score
AMEX:ARMP Key Ratios
Market Cap $ M | 83.58 |
Enterprise Value $ M | 202.96 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.35 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 56.20 |
5-y EBITDA Growth Rate % | 23.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.39 |
EV-to-EBITDA | -3.46 |
PEG | -- |
Shares Outstanding M | 36.18 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.25 |
Current Ratio | 0.25 |
ROA % (ttm) | -61.96 |
ROE % (ttm) | -- |
ROIC % (ttm) | -30.99 |
Dividend Yield % | -- |
Altman Z-Score | -- |
ARMP Number of Guru Trades
ARMP Volume of Guru Trades
Gurus Latest Trades with AMEX:ARMP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ARMP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Armata Pharmaceuticals Inc Insider Transactions
No Available Data
News about AMEX:ARMP
Total 0- 1